FTXH ETF

$34.87

Returns Overview

1 Month
+1.94%
3 Months
-1.02%
6 Months
+7.95%
YTD
+5.44%
1 Year
+27.73%
3 Years
+12.26%
5 Years
+8.13%

Risk Metrics (1-Year)

No risk data available for this ETF

Stress Test Scenarios

How would FTXH have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
🔒Upgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
🔒Upgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
🔒Upgrade to run

1 Month Performance

+1.94%

3 Months Performance

-1.02%

6 Months Performance

+7.95%

1 Year Performance

+27.73%

Benchmark & Peers

Benchmark
Nasdaq US Smart Pharmaceuticals Index(NQSSPH)
This ETF (YTD)
+5.44%
Peer Avg (YTD)
+1.55%
vs Peers
+3.90%

FTXH ETF Performance

FTXH performance across multiple time periods: 1-month 1.94%, YTD 5.44%, 1-year 27.73%, 3-year 12.26%, 5-year 8.13%.

FTXH returns outperform the peer average of 1.55% YTD. With an expense ratio of 0.60%, investors should weigh costs against performance when evaluating this ETF.

FTXH performance comparison shows side-by-side returns with another fund. FTXH alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month+1.94%Apr 22, 2026 to May 22, 2026
3 Months-1.02%Feb 23, 2026 to May 22, 2026
6 Months+7.95%Nov 24, 2025 to May 22, 2026
1 Year+27.73%N/A
3 Years+12.26%N/A
5 Years+8.13%N/A

All returns shown are total returns, not annualized